Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STARSOURCE MULTITRADE LIMITED Board/Management Information 2025

Sep 12, 2025

63364_rns_2025-09-12_0a320f68-7f74-4889-8207-8633b0afa600.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

CHEMO PHARMA LABORATORIES LTD

Registered Office : 5-Kumud Apartment Co. Op. HSG. SOC. Ltd, Karnik Road, Chikan Ghar, Kalyan, Dist. Thane – 421301

Corporate Office: Office No 1016 North Plaza Near D Mart, Visat Gandhinagar Highway, Motera, Ahmedabad, Gujarat, India, 380005

Tel No.:022-22078382 [CIN: L99999MH1942PLC003556]

Website: www.thechemopharmalaboratoriesltd.com Email : [email protected] Date: September 12, 2025

To, Bombay Stock Exchange Limited Department of Corporate Services, 25th Floor, P. J. Towers, Dalal Street, Mumbai-400001 Script Id: 506365 ISIN: INE320M01019

Subject: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Company Secretary & Compliance Officer

Dear Sir,

Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you that Ms. Bhawna Rajput (ACS 72357) has tendered her resignation from the post of Company Secretary and Compliance Officer of the company vide her letter dated September 12, 2025 to due to preoccupancy in other assignments. The Company has accepted and taken on record her resignation and will complete necessary formalities in regards of her resignation in due course of time. She will be relieved from her responsibilities w.e.f. September 12, 2025. Copy of her resignation letter is enclosed herewith.

The details required under the SEBI Listing Regulations and SEBI Circular No. SEBI/HO/ CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July 2023 (‘SEBI Circular) are attached herewith as Annexure A .

Further, the Board of Directors of the Company in their Board Meeting held on today i.e. Friday, September 12, 2025 which was commenced at 03.15 PM at the registered Office of the Company have considered and have, inter alia, approved appointment of Mr. Aditya Agarwal (ACS 53202) as Company Secretary & Compliance Officer of the Company w.e.f. September 12, 2025. The Details for the above mentioned required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015) are given in Annexure B . Please note that the meeting concluded at 03.45 PM.

Kindly take the same on your records.

Thanking You. Yours Faithfully,

FOR CHEMO PHARMA LABORATORIES LIMITED

==> picture [109 x 26] intentionally omitted <==

==> picture [73 x 66] intentionally omitted <==

RUCHIT MEHTA Managing Director & Chief Executive Officer DIN: 08810586

Annexure A

Details pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Read with Schedule III of these Regulations and SEBI circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123, dated 13th July, 2023 with respect to resignation of Company Secretary & Compliance Officer of the Company

Sr. No. Particulars Details
1 Name ofthe Company ChemoPharmaLaboratoriesLimited
2 Name ofCompany Secretary Ms.BhawnaRajput (ACS72357)
3 Reasons of change viz.
appointment, resignation,
removal, deathorotherwise
Pre-occupation in other assignments as
mentioned in resignation letter dated
September 12, 2025.
4 Effective date of resignation September 12, 2025.
5 Briefprofile Not applicable
6 Disclosure of relationship
between directors (in case of
appointment ofa director
Not applicable
7 Information as required pursuant
to BSE Circular with ref. no.
LIST/ COMP/ 14/ 2018- 19 and
the National Stock Exchange of
India Ltd with ref. no.
NSE/CML/2018/24, dated 20th
June 2018
Not Applicable

==> picture [73 x 66] intentionally omitted <==

==> picture [414 x 250] intentionally omitted <==

==> picture [414 x 250] intentionally omitted <==

Annexure B

Information as required in terms of the Circular under Regulation 30 of Listing Regulations: Appointment of Mr. Aditya Agarwal (ACS 53202) as a Company Secretary and Compliance officer of the Company.

Sr. No. Particulars Details
1 Name ofthe Company ChemoPharmaLaboratoriesLimited
2 Name ofCompany Secretary Mr.AdityaAgarwal(ACS 53202)
3 Reasons of change viz.
appointment, resignation,
removal, death or otherwise
Mr. Aditya Agarwal has been appointed
as a Company Secretary & Compliance
Officer by the Board with effect from
September 12, 2025
4 Date of Appointment & Terms of
appointment
September 12, 2025.
5 Brief profile Mr. Aditya Agarwal is a qualified
Company Secretary with expertise in
legal, secretarial, and listing
compliances, complemented by an MBA
& M.Com degree. Possesses experience
with a proven ability to independently
manage statutory requirements while
contributing to organizational growth. A
collaborative team player with an
ownership mindset and a focus on
delivering high quality strategic
solutions to complexchallenges.
6 Disclosure of relationship
between directors (in case of
appointment ofa director
Not related to any existing directors of
the Company.
7 Information as required pursuant
to BSE Circular with ref. no.
LIST/COMP/14/2018-19 and
the National Stock Exchange of
India Ltd with ref. no.
NSE/CML/2018/24, dated 20th
June 2018
Not Applicable

==> picture [73 x 66] intentionally omitted <==